NewcelX Ltd. (NCEL) director buys shares and long-dated warrants

Rhea-AI Filing Summary

NewcelX Ltd. director Samuel Olivier reported open-market purchases of both common shares and warrants. He bought 81,818 common shares of NewcelX at $2.75 per share, with each share sold together with a warrant according to the footnote.

Olivier also acquired 114,545 warrants, each exercisable at $3.025 per common share and expiring on April 27, 2031. Following these transactions, he directly holds 81,818 common shares and 114,545 warrants, reflecting a net addition of 196,363 share-equivalents to his position.

Insider Trade Summary

Net Buyer: 196,363 shares ($225,000)

Net Buy 2 txns

Insider Samuel Olivier

Role null

Bought 196,363 shs ($225K)

Type	Security	Shares	Price	Value
Purchase	Warrant (right to buy)	114,545	$0.00	--
Purchase	Common Shares, par value CHF 0.05 per share	81,818	$2.75	$225K

Holdings After Transaction: Warrant (right to buy) — 114,545 shares (Direct, null); Common Shares, par value CHF 0.05 per share — 81,818 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Common shares purchased: 81,818 shares Share purchase price: $2.75 per share Warrants acquired: 114,545 warrants +5 more

8 metrics

Common shares purchased 81,818 shares Open-market purchase on April 27, 2026

Share purchase price $2.75 per share Combined price per common share and accompanying warrant

Warrants acquired 114,545 warrants Right to buy common shares, acquired April 27, 2026

Warrant exercise price $3.025 per share Exercise price for each warrant into one common share

Warrant expiration April 27, 2031 Expiration date of acquired warrants

Net shares and equivalents bought 196,363 share-equivalents Sum of common shares and underlying warrant shares

Shares held after transaction 81,818 shares Direct common share holdings following the purchases

Warrants held after transaction 114,545 warrants Warrant holdings following the purchases

Key Terms

open-market purchase, warrant, par value, exercise price, +1 more

5 terms

open-market purchase financial

"transaction_action": "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

warrant financial

"accompanying one warrant to purchase Common Share was $2.75"

A warrant is a time-limited financial contract that gives its holder the right to buy a company's shares at a set price before a specified date, like a coupon that lets you purchase stock at a fixed discount for a limited time. It matters to investors because warrants offer leveraged exposure to a stock’s upside and can dilute existing shareholders if exercised, so they affect potential gains and the company’s outstanding share count.

par value financial

"Common Shares, par value CHF 0.05 per share"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

exercise price financial

"conversion_or_exercise_price": "3.0250""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

derivative financial

"transaction_type": "derivative""

A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Samuel Olivier

(Last) (First) (Middle)

C/O NEWCELX LTD.

HOHSTRASSE 1

(Street)

KLOTEN 8302

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
NewcelX Ltd. [ NCEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, par value CHF 0.05 per share	04/27/2026		P		81,818	A	$2.75(1)	81,818	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant (right to buy)	$3.025	04/27/2026		P		114,545		04/27/2026	04/27/2031	Common Shares, par value CHF 0.05 per share	114,545	(1)	114,545	D

Explanation of Responses:

1. The combined purchase price per one common share, par value CHF 0.05 per share ("Common Share"), and accompanying one warrant to purchase Common Share was $2.75.

	/s/ Olivier Samuel	04/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did NewcelX (NCEL) director Samuel Olivier report?

Samuel Olivier reported buying NewcelX securities. He acquired 81,818 common shares and 114,545 warrants in open-market purchases, increasing both his direct share ownership and his right to buy additional shares through warrants at a set exercise price.

How many NewcelX (NCEL) common shares did Samuel Olivier buy and at what price?

Samuel Olivier purchased 81,818 NewcelX common shares. The reported price was $2.75 per share, with a footnote explaining this was the combined purchase price for one common share and one accompanying warrant, reflecting a unit-style structure for the transaction.

What warrants did NewcelX (NCEL) director Samuel Olivier acquire?

He acquired 114,545 warrants, each giving the right to buy one NewcelX common share. These warrants have an exercise price of $3.025 per share and an expiration date of April 27, 2031, creating a long-dated derivative position linked to the company’s common stock.

What is the combined purchase structure noted in the NewcelX (NCEL) Form 4 footnote?

The footnote states the combined purchase price for one NewcelX common share and one accompanying warrant was $2.75. This indicates investors, including Samuel Olivier, bought units consisting of a share plus a warrant, rather than purchasing the securities separately at different cash prices.

What are Samuel Olivier’s NewcelX (NCEL) holdings after these transactions?

After the reported trades, Samuel Olivier directly holds 81,818 NewcelX common shares and 114,545 warrants. The transactions represent a net addition of 196,363 share-equivalents, combining current share ownership and the potential shares underlying his newly acquired warrants.

When do Samuel Olivier’s NewcelX (NCEL) warrants expire and what is the exercise price?

The warrants acquired by Samuel Olivier expire on April 27, 2031. Each warrant is exercisable into one NewcelX common share at an exercise price of $3.025 per share, defining the cost to convert each warrant into underlying equity in the future.